PSMA is a 100-kDa transmembrane peptidase upregulated primarily in prostate cancer cells as well as in endothelial cells of solid tumours of the breast, lung, thyroid, pancreas, and urothelium, including sarcomas and primary glial tumours. This evidence concerns the gene FOLH1 and prostate carcinoma.